

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.74003246 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.74003246 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.54765820 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.50526315 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.50526315 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.36318944 |
| 7 | negative regulation of cell killing (GO:0031342) | 6.36318944 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.12221415 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.12221415 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 6.12221415 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 6.12221415 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 6.12221415 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.12221415 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 6.11391387 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.88264118 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 5.81479365 |
| 17 | detection of other organism (GO:0098543) | 5.77947821 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.73267604 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.69785712 |
| 20 | detection of bacterium (GO:0016045) | 5.64926626 |
| 21 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.57558394 |
| 22 | indole-containing compound catabolic process (GO:0042436) | 5.56713214 |
| 23 | indolalkylamine catabolic process (GO:0046218) | 5.56713214 |
| 24 | tryptophan catabolic process (GO:0006569) | 5.56713214 |
| 25 | kynurenine metabolic process (GO:0070189) | 5.51933830 |
| 26 | glyoxylate metabolic process (GO:0046487) | 5.39498647 |
| 27 | bile acid biosynthetic process (GO:0006699) | 5.29163522 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 5.28808192 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.28073822 |
| 30 | tryptophan metabolic process (GO:0006568) | 5.23703748 |
| 31 | leukocyte aggregation (GO:0070486) | 5.18257426 |
| 32 | urea cycle (GO:0000050) | 5.16204991 |
| 33 | urea metabolic process (GO:0019627) | 5.16204991 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.15051125 |
| 35 | complement activation, alternative pathway (GO:0006957) | 5.08376155 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 5.08076844 |
| 37 | protein carboxylation (GO:0018214) | 5.07024355 |
| 38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.07024355 |
| 39 | negative regulation of fibrinolysis (GO:0051918) | 5.00567745 |
| 40 | cysteine metabolic process (GO:0006534) | 4.98669992 |
| 41 | detection of external biotic stimulus (GO:0098581) | 4.98356933 |
| 42 | response to peptidoglycan (GO:0032494) | 4.96099556 |
| 43 | high-density lipoprotein particle remodeling (GO:0034375) | 4.95166671 |
| 44 | macrophage activation involved in immune response (GO:0002281) | 4.94581318 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91230804 |
| 46 | nitrogen cycle metabolic process (GO:0071941) | 4.76727679 |
| 47 | regulation of protein activation cascade (GO:2000257) | 4.76704135 |
| 48 | regulation of fibrinolysis (GO:0051917) | 4.71328451 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 4.68883459 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 4.68658139 |
| 51 | respiratory burst (GO:0045730) | 4.62214156 |
| 52 | serine family amino acid catabolic process (GO:0009071) | 4.58359952 |
| 53 | lysine metabolic process (GO:0006553) | 4.53436337 |
| 54 | lysine catabolic process (GO:0006554) | 4.53436337 |
| 55 | neutrophil activation (GO:0042119) | 4.51612442 |
| 56 | regulation of complement activation (GO:0030449) | 4.49310280 |
| 57 | bile acid metabolic process (GO:0008206) | 4.48251467 |
| 58 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.47574350 |
| 59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.43301206 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 4.40171313 |
| 61 | homocysteine metabolic process (GO:0050667) | 4.36636123 |
| 62 | reverse cholesterol transport (GO:0043691) | 4.32427602 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 4.32401987 |
| 64 | cellular extravasation (GO:0045123) | 4.32383722 |
| 65 | detection of biotic stimulus (GO:0009595) | 4.31227259 |
| 66 | plasma lipoprotein particle remodeling (GO:0034369) | 4.30280279 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 4.30280279 |
| 68 | macromolecular complex remodeling (GO:0034367) | 4.30280279 |
| 69 | regulation of cholesterol esterification (GO:0010872) | 4.29942285 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.29273261 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.27718576 |
| 72 | response to host immune response (GO:0052572) | 4.26524074 |
| 73 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.26524074 |
| 74 | phospholipid efflux (GO:0033700) | 4.21947191 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 4.20332660 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 4.19119617 |
| 77 | tyrosine metabolic process (GO:0006570) | 4.17564832 |
| 78 | immunoglobulin mediated immune response (GO:0016064) | 4.16560949 |
| 79 | acylglycerol homeostasis (GO:0055090) | 4.12914297 |
| 80 | triglyceride homeostasis (GO:0070328) | 4.12914297 |
| 81 | response to interleukin-15 (GO:0070672) | 4.10730136 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 4.10081504 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 4.08456975 |
| 84 | negative regulation of sterol transport (GO:0032372) | 4.08456975 |
| 85 | coenzyme catabolic process (GO:0009109) | 4.07535051 |
| 86 | granulocyte activation (GO:0036230) | 4.04621702 |
| 87 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.99518858 |
| 88 | ethanol oxidation (GO:0006069) | 3.95390721 |
| 89 | aldehyde catabolic process (GO:0046185) | 3.95242247 |
| 90 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.92333331 |
| 91 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.91643819 |
| 92 | response to host (GO:0075136) | 3.91643819 |
| 93 | response to host defenses (GO:0052200) | 3.91643819 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 3.90234804 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.87787289 |
| 96 | cellular modified amino acid catabolic process (GO:0042219) | 3.86570107 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 3.86185800 |
| 98 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.84732490 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.84046629 |
| 100 | cellular glucuronidation (GO:0052695) | 3.83861749 |
| 101 | microglial cell activation (GO:0001774) | 3.83617196 |
| 102 | glycine metabolic process (GO:0006544) | 3.81695662 |
| 103 | bile acid and bile salt transport (GO:0015721) | 3.81660160 |
| 104 | cellular biogenic amine catabolic process (GO:0042402) | 3.80789769 |
| 105 | amine catabolic process (GO:0009310) | 3.80789769 |
| 106 | neutrophil mediated immunity (GO:0002446) | 3.79807745 |
| 107 | regulation of mast cell degranulation (GO:0043304) | 3.78638112 |
| 108 | cholesterol efflux (GO:0033344) | 3.78609231 |
| 109 | negative regulation of phagocytosis (GO:0050765) | 3.77081336 |
| 110 | benzene-containing compound metabolic process (GO:0042537) | 3.75396125 |
| 111 | glutamate metabolic process (GO:0006536) | 3.74030117 |
| 112 | serine family amino acid metabolic process (GO:0009069) | 3.73488612 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.72638775 |
| 114 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.72165604 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 3.71840107 |
| 116 | positive regulation of lipid catabolic process (GO:0050996) | 3.71333590 |
| 117 | cellular response to interleukin-15 (GO:0071350) | 3.71254238 |
| 118 | fibrinolysis (GO:0042730) | 3.68230075 |
| 119 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.67967520 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.65396932 |
| 121 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.64821433 |
| 122 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.64821433 |
| 123 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.64245242 |
| 124 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64158570 |
| 125 | type I interferon signaling pathway (GO:0060337) | 3.62758345 |
| 126 | cellular response to type I interferon (GO:0071357) | 3.62758345 |
| 127 | plasma lipoprotein particle assembly (GO:0034377) | 3.62613675 |
| 128 | cofactor catabolic process (GO:0051187) | 3.62558721 |
| 129 | arginine metabolic process (GO:0006525) | 3.60653650 |
| 130 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.59687794 |
| 131 | response to type I interferon (GO:0034340) | 3.59134964 |
| 132 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.57028755 |
| 133 | macrophage activation (GO:0042116) | 3.56033073 |
| 134 | low-density lipoprotein particle remodeling (GO:0034374) | 3.53429735 |
| 135 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.52470305 |
| 136 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.52470305 |
| 137 | drug catabolic process (GO:0042737) | 3.52383523 |
| 138 | ketone body metabolic process (GO:1902224) | 3.52170812 |
| 139 | carboxylic acid catabolic process (GO:0046395) | 3.50811695 |
| 140 | organic acid catabolic process (GO:0016054) | 3.50811695 |
| 141 | short-chain fatty acid metabolic process (GO:0046459) | 3.50749989 |
| 142 | cholesterol homeostasis (GO:0042632) | 3.49926878 |
| 143 | 2-oxoglutarate metabolic process (GO:0006103) | 3.49877871 |
| 144 | fatty acid beta-oxidation (GO:0006635) | 3.47115912 |
| 145 | glucuronate metabolic process (GO:0019585) | 3.46628088 |
| 146 | uronic acid metabolic process (GO:0006063) | 3.46628088 |
| 147 | serine family amino acid biosynthetic process (GO:0009070) | 3.46411509 |
| 148 | fatty acid oxidation (GO:0019395) | 3.45560729 |
| 149 | regulation of cholesterol homeostasis (GO:2000188) | 3.45522560 |
| 150 | sterol homeostasis (GO:0055092) | 3.45394430 |
| 151 | acute-phase response (GO:0006953) | 3.45282230 |
| 152 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.42900945 |
| 153 | complement activation (GO:0006956) | 3.42687058 |
| 154 | lipid oxidation (GO:0034440) | 3.40206963 |
| 155 | complement activation, classical pathway (GO:0006958) | 3.38919501 |
| 156 | aspartate family amino acid catabolic process (GO:0009068) | 3.37106370 |
| 157 | monocarboxylic acid catabolic process (GO:0072329) | 3.36778213 |
| 158 | B cell mediated immunity (GO:0019724) | 3.36418809 |
| 159 | plasma lipoprotein particle organization (GO:0071827) | 3.35753675 |
| 160 | leukocyte degranulation (GO:0043299) | 3.35482323 |
| 161 | regulation of leukocyte degranulation (GO:0043300) | 3.34098212 |
| 162 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29461523 |
| 163 | myeloid leukocyte mediated immunity (GO:0002444) | 3.22101850 |
| 164 | regulation of T cell tolerance induction (GO:0002664) | 3.19857450 |
| 165 | positive regulation of mast cell activation (GO:0033005) | 3.15509380 |
| 166 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.11658479 |
| 167 | regulation of tolerance induction (GO:0002643) | 3.10534471 |
| 168 | regulation of mast cell activation (GO:0033003) | 3.09932914 |
| 169 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.08289511 |
| 170 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06764205 |
| 171 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.06460721 |
| 172 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.06398412 |
| 173 | B cell receptor signaling pathway (GO:0050853) | 3.05817401 |
| 174 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.05749631 |
| 175 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.05548478 |
| 176 | negative regulation of innate immune response (GO:0045824) | 3.03345610 |
| 177 | negative regulation of interleukin-6 production (GO:0032715) | 3.01895192 |
| 178 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00251238 |
| 179 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.99630667 |
| 180 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.99630667 |
| 181 | defense response to protozoan (GO:0042832) | 2.99619984 |
| 182 | regulation of B cell differentiation (GO:0045577) | 2.98838500 |
| 183 | dendritic cell chemotaxis (GO:0002407) | 2.97957831 |
| 184 | dendritic cell migration (GO:0036336) | 2.96807775 |
| 185 | regulation of regulated secretory pathway (GO:1903305) | 2.94382393 |
| 186 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94186322 |
| 187 | response to interferon-alpha (GO:0035455) | 2.93452192 |
| 188 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92504451 |
| 189 | germinal center formation (GO:0002467) | 2.91257889 |
| 190 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87788197 |
| 191 | positive regulation of B cell differentiation (GO:0045579) | 2.87639647 |
| 192 | neutrophil chemotaxis (GO:0030593) | 2.84553973 |
| 193 | negative regulation of type 2 immune response (GO:0002829) | 2.83088168 |
| 194 | positive regulation of interferon-alpha production (GO:0032727) | 2.83036524 |
| 195 | myeloid leukocyte activation (GO:0002274) | 2.80212977 |
| 196 | response to muramyl dipeptide (GO:0032495) | 2.79062632 |
| 197 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.78631028 |
| 198 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.78192709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.38469835 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.49201371 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.83585429 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.75271330 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.29753018 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.66011982 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.41085097 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.51232974 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.34661015 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.96773471 |
| 11 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.81463048 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.59571611 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58782532 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.50012800 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.37121513 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.34286112 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.26661624 |
| 18 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19958559 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10050763 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.09852076 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.04942491 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4442348 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.95788623 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95041672 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.91773659 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91541033 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89425056 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86870492 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.86739134 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.85317177 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85249011 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82699267 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81431873 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80174382 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79135517 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.79089238 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79080185 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78234079 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.77722843 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75805764 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.75067143 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73379099 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72152512 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.69146287 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62834627 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62268065 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58799205 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55749721 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55600707 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53624262 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53275122 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50743254 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49545953 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45339805 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43099393 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42474318 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40414358 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37986211 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37744331 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36534944 |
| 61 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36476946 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36104342 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34920142 |
| 64 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33230047 |
| 65 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33022808 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28862927 |
| 67 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27617424 |
| 68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24196684 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23704203 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20523733 |
| 71 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19345014 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14963775 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14707284 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14662418 |
| 75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14390950 |
| 76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.14067354 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13308079 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10244114 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07005860 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06940352 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05865708 |
| 82 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05660444 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04921914 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04397854 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03551116 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01467706 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01153525 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00802723 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99927681 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 0.99350516 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95270530 |
| 92 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94690687 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94162731 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92250486 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91103671 |
| 96 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90692428 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90691021 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89275919 |
| 99 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82601066 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81924261 |
| 101 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81506787 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81441271 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80836687 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80786261 |
| 105 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80379395 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80055425 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77502083 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77397842 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77195863 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76179523 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73766799 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71401002 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71375859 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71375859 |
| 115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71021314 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.70280336 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70205288 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69841885 |
| 119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69662100 |
| 120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68441075 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67932858 |
| 122 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67701953 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.67583104 |
| 124 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.67101658 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66938082 |
| 126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.66935436 |
| 127 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.66349653 |
| 128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.66113645 |
| 129 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65123409 |
| 130 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64778275 |
| 131 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.61363228 |
| 132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.61272595 |
| 133 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61107826 |
| 134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60877674 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60562490 |
| 136 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.59567508 |
| 137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59549485 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59504360 |
| 139 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.58470841 |
| 140 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.57834424 |
| 141 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57556812 |
| 142 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.57176634 |
| 143 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.57176634 |
| 144 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.56937602 |
| 145 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56915039 |
| 146 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.56486563 |
| 147 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.55806161 |
| 148 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.55697524 |
| 149 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.55305796 |
| 150 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.54988390 |
| 151 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.54578102 |
| 152 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.54305925 |
| 153 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.53531855 |
| 154 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.53510712 |
| 155 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.53421528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.25305566 |
| 2 | MP0005360_urolithiasis | 6.67989790 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.57998204 |
| 4 | MP0005365_abnormal_bile_salt | 5.39686276 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.40402839 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.85984477 |
| 7 | MP0009840_abnormal_foam_cell | 3.45585557 |
| 8 | MP0003252_abnormal_bile_duct | 3.40122489 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.23299270 |
| 10 | MP0005083_abnormal_biliary_tract | 2.98858345 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.69473775 |
| 12 | MP0001800_abnormal_humoral_immune | 2.68678313 |
| 13 | MP0005671_abnormal_response_to | 2.67182923 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.62693035 |
| 15 | MP0005332_abnormal_amino_acid | 2.57891565 |
| 16 | MP0008260_abnormal_autophagy | 2.52546465 |
| 17 | MP0002132_abnormal_respiratory_system | 2.51270789 |
| 18 | MP0003195_calcinosis | 2.49587379 |
| 19 | MP0002723_abnormal_immune_serum | 2.46240842 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.42714616 |
| 21 | MP0001819_abnormal_immune_cell | 2.40478311 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.36471339 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.32961388 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.19746068 |
| 25 | MP0000609_abnormal_liver_physiology | 2.10595899 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 2.02056019 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.00569043 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.99009552 |
| 29 | MP0002405_respiratory_system_inflammati | 1.93064566 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.89169868 |
| 31 | MP0002398_abnormal_bone_marrow | 1.82362535 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.81395629 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.79577893 |
| 34 | MP0000716_abnormal_immune_system | 1.79078620 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.76363592 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.74631095 |
| 37 | MP0003828_pulmonary_edema | 1.65562019 |
| 38 | MP0003866_abnormal_defecation | 1.62596898 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.60382695 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.59984982 |
| 41 | MP0009278_abnormal_bone_marrow | 1.59952637 |
| 42 | MP0005451_abnormal_body_composition | 1.58377483 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56305647 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.56073984 |
| 45 | MP0002722_abnormal_immune_system | 1.55652949 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.55261561 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.53687904 |
| 48 | MP0001764_abnormal_homeostasis | 1.53533468 |
| 49 | MP0003436_decreased_susceptibility_to | 1.52363109 |
| 50 | MP0003186_abnormal_redox_activity | 1.52071615 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.50318942 |
| 52 | MP0002429_abnormal_blood_cell | 1.46391383 |
| 53 | MP0009764_decreased_sensitivity_to | 1.43235534 |
| 54 | MP0003868_abnormal_feces_composition | 1.40640945 |
| 55 | MP0000858_altered_metastatic_potential | 1.39085087 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.37898400 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.35263881 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.31602852 |
| 59 | MP0004381_abnormal_hair_follicle | 1.30687340 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.29706222 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.28285185 |
| 62 | MP0003011_delayed_dark_adaptation | 1.23589348 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.21654546 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.21654546 |
| 65 | MP0008469_abnormal_protein_level | 1.21139154 |
| 66 | MP0000598_abnormal_liver_morphology | 1.16367419 |
| 67 | MP0001851_eye_inflammation | 1.14986293 |
| 68 | MP0000604_amyloidosis | 1.14049281 |
| 69 | MP0009763_increased_sensitivity_to | 1.10701569 |
| 70 | MP0004130_abnormal_muscle_cell | 1.10620073 |
| 71 | MP0005310_abnormal_salivary_gland | 1.07715856 |
| 72 | MP0003303_peritoneal_inflammation | 1.07237327 |
| 73 | MP0003724_increased_susceptibility_to | 1.07154388 |
| 74 | MP0005670_abnormal_white_adipose | 1.04140454 |
| 75 | MP0000490_abnormal_crypts_of | 0.97951248 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.94725523 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.94666483 |
| 78 | MP0005464_abnormal_platelet_physiology | 0.94605314 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 0.94186372 |
| 80 | MP0002254_reproductive_system_inflammat | 0.93302595 |
| 81 | MP0009697_abnormal_copulation | 0.93117423 |
| 82 | MP0002971_abnormal_brown_adipose | 0.91201436 |
| 83 | MP0009785_altered_susceptibility_to | 0.90959332 |
| 84 | MP0006082_CNS_inflammation | 0.90854798 |
| 85 | MP0005647_abnormal_sex_gland | 0.89320139 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.88255346 |
| 87 | MP0002419_abnormal_innate_immunity | 0.86741199 |
| 88 | MP0003075_altered_response_to | 0.85467011 |
| 89 | MP0005390_skeleton_phenotype | 0.85048568 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.81971779 |
| 91 | MP0003878_abnormal_ear_physiology | 0.81971779 |
| 92 | MP0001663_abnormal_digestive_system | 0.81707111 |
| 93 | MP0004858_abnormal_nervous_system | 0.79876557 |
| 94 | MP0001853_heart_inflammation | 0.79745703 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.79644383 |
| 96 | MP0005334_abnormal_fat_pad | 0.79232712 |
| 97 | MP0003300_gastrointestinal_ulcer | 0.78992201 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 0.78970612 |
| 99 | MP0003690_abnormal_glial_cell | 0.78334241 |
| 100 | MP0003448_altered_tumor_morphology | 0.74949419 |
| 101 | MP0005025_abnormal_response_to | 0.74521261 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.74015300 |
| 103 | MP0001845_abnormal_inflammatory_respons | 0.73361064 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.72624245 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.72093733 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.71947688 |
| 107 | MP0010368_abnormal_lymphatic_system | 0.70386014 |
| 108 | MP0005535_abnormal_body_temperature | 0.69993203 |
| 109 | MP0005166_decreased_susceptibility_to | 0.69104586 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.68471040 |
| 111 | MP0001873_stomach_inflammation | 0.68271339 |
| 112 | MP0000343_altered_response_to | 0.68228966 |
| 113 | MP0005084_abnormal_gallbladder_morpholo | 0.68172899 |
| 114 | MP0002166_altered_tumor_susceptibility | 0.67098352 |
| 115 | MP0005408_hypopigmentation | 0.66504238 |
| 116 | MP0001756_abnormal_urination | 0.66390277 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.64383702 |
| 118 | MP0008004_abnormal_stomach_pH | 0.63907850 |
| 119 | MP0001835_abnormal_antigen_presentation | 0.63362647 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.63249483 |
| 121 | MP0004782_abnormal_surfactant_physiolog | 0.61985829 |
| 122 | MP0003045_fibrosis | 0.61418109 |
| 123 | MP0003795_abnormal_bone_structure | 0.60359993 |
| 124 | MP0005266_abnormal_metabolism | 0.59095692 |
| 125 | MP0004947_skin_inflammation | 0.58581065 |
| 126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57856270 |
| 127 | MP0005448_abnormal_energy_balance | 0.56543019 |
| 128 | MP0005220_abnormal_exocrine_pancreas | 0.54748449 |
| 129 | MP0000249_abnormal_blood_vessel | 0.53527199 |
| 130 | MP0001881_abnormal_mammary_gland | 0.53158745 |
| 131 | MP0001661_extended_life_span | 0.53015309 |
| 132 | MP0009115_abnormal_fat_cell | 0.52825536 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.52715221 |
| 134 | MP0002019_abnormal_tumor_incidence | 0.52651743 |
| 135 | MP0008873_increased_physiological_sensi | 0.52242557 |
| 136 | MP0003329_amyloid_beta_deposits | 0.52148165 |
| 137 | MP0003453_abnormal_keratinocyte_physiol | 0.52141414 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.51699198 |
| 139 | MP0005164_abnormal_response_to | 0.51655249 |
| 140 | MP0004883_abnormal_blood_vessel | 0.50106989 |
| 141 | MP0000685_abnormal_immune_system | 0.48162657 |
| 142 | MP0006035_abnormal_mitochondrial_morpho | 0.47753155 |
| 143 | MP0002796_impaired_skin_barrier | 0.45455962 |
| 144 | MP0001790_abnormal_immune_system | 0.45008117 |
| 145 | MP0005387_immune_system_phenotype | 0.45008117 |
| 146 | MP0008874_decreased_physiological_sensi | 0.44522939 |
| 147 | MP0005023_abnormal_wound_healing | 0.44379547 |
| 148 | MP0009053_abnormal_anal_canal | 0.44268157 |
| 149 | MP0002928_abnormal_bile_duct | 0.43542924 |
| 150 | MP0004510_myositis | 0.40561431 |
| 151 | MP0002876_abnormal_thyroid_physiology | 0.40119658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.58389463 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.44842987 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.42816564 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 6.23217032 |
| 5 | Myositis (HP:0100614) | 5.92176655 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.88473034 |
| 7 | Xanthomatosis (HP:0000991) | 5.77533461 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.77244330 |
| 9 | Orchitis (HP:0100796) | 5.53849352 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 5.48426751 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 5.23877708 |
| 12 | Complement deficiency (HP:0004431) | 5.05465427 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 5.01950074 |
| 14 | Optic neuritis (HP:0100653) | 4.99291448 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 4.99291448 |
| 16 | Stomatitis (HP:0010280) | 4.82812101 |
| 17 | Obstructive lung disease (HP:0006536) | 4.70610847 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 4.70610847 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.63072368 |
| 20 | Joint hemorrhage (HP:0005261) | 4.62336104 |
| 21 | Hyperammonemia (HP:0001987) | 4.28732869 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 4.26775247 |
| 23 | Hypolipoproteinemia (HP:0010981) | 4.12899597 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 4.10811905 |
| 25 | Meningitis (HP:0001287) | 4.10611527 |
| 26 | Ketosis (HP:0001946) | 4.09464768 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 4.09415342 |
| 28 | Hypochromic anemia (HP:0001931) | 3.97572601 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.95756930 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.94820316 |
| 31 | Recurrent skin infections (HP:0001581) | 3.94221438 |
| 32 | Epidermoid cyst (HP:0200040) | 3.93532314 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.89901016 |
| 34 | Hyperglycinemia (HP:0002154) | 3.87352178 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.86168584 |
| 36 | Urticaria (HP:0001025) | 3.85220313 |
| 37 | Abnormality of complement system (HP:0005339) | 3.84169976 |
| 38 | Hypoalphalipoproteinemia (HP:0003233) | 3.82761687 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.82211402 |
| 40 | Hyperglycinuria (HP:0003108) | 3.81778788 |
| 41 | Encephalitis (HP:0002383) | 3.80931481 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.78477835 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.67561632 |
| 44 | Abnormality of glycine metabolism (HP:0010895) | 3.67561632 |
| 45 | Hypoglycemic coma (HP:0001325) | 3.65844395 |
| 46 | Fat malabsorption (HP:0002630) | 3.64960814 |
| 47 | Increased IgE level (HP:0003212) | 3.64641297 |
| 48 | Keratoconjunctivitis sicca (HP:0001097) | 3.62479118 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.61157840 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 3.57436285 |
| 51 | Gingivitis (HP:0000230) | 3.54647860 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.51440140 |
| 53 | Prolonged bleeding time (HP:0003010) | 3.43492218 |
| 54 | Spontaneous hematomas (HP:0007420) | 3.40813621 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 3.38122595 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33157930 |
| 57 | Keratoconjunctivitis (HP:0001096) | 3.31641124 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 3.31261818 |
| 59 | Hypercholesterolemia (HP:0003124) | 3.30329964 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 3.29641681 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.29641681 |
| 62 | Episodic fever (HP:0001954) | 3.28509607 |
| 63 | Vasculitis (HP:0002633) | 3.24835124 |
| 64 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.23854288 |
| 65 | Myocardial infarction (HP:0001658) | 3.23131378 |
| 66 | Cellulitis (HP:0100658) | 3.22474717 |
| 67 | Petechiae (HP:0000967) | 3.16005697 |
| 68 | Anorexia (HP:0002039) | 3.10561261 |
| 69 | Chest pain (HP:0100749) | 3.05686089 |
| 70 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03119071 |
| 71 | Ketoacidosis (HP:0001993) | 3.02580532 |
| 72 | Peritonitis (HP:0002586) | 2.93137376 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.92751462 |
| 74 | Hyperbilirubinemia (HP:0002904) | 2.91107529 |
| 75 | Conjugated hyperbilirubinemia (HP:0002908) | 2.89421110 |
| 76 | Steatorrhea (HP:0002570) | 2.87424753 |
| 77 | Epistaxis (HP:0000421) | 2.85867304 |
| 78 | Microcytic anemia (HP:0001935) | 2.85577555 |
| 79 | Hemoptysis (HP:0002105) | 2.71731923 |
| 80 | Purpura (HP:0000979) | 2.69791217 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.67071195 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.67071195 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.66892498 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.66886111 |
| 85 | Skin nodule (HP:0200036) | 2.66129992 |
| 86 | Metabolic acidosis (HP:0001942) | 2.64675085 |
| 87 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.64362740 |
| 88 | Hepatocellular carcinoma (HP:0001402) | 2.64029639 |
| 89 | Inflammation of the large intestine (HP:0002037) | 2.61912339 |
| 90 | Gout (HP:0001997) | 2.61383910 |
| 91 | Delayed CNS myelination (HP:0002188) | 2.61046097 |
| 92 | Vascular calcification (HP:0004934) | 2.59996627 |
| 93 | Osteomyelitis (HP:0002754) | 2.59372014 |
| 94 | Arterial thrombosis (HP:0004420) | 2.58988024 |
| 95 | Increased IgM level (HP:0003496) | 2.58810174 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.58752244 |
| 97 | Glomerulonephritis (HP:0000099) | 2.56200154 |
| 98 | Panhypogammaglobulinemia (HP:0003139) | 2.53336099 |
| 99 | Amyloidosis (HP:0011034) | 2.50985618 |
| 100 | Leukocytosis (HP:0001974) | 2.49569480 |
| 101 | Hepatosplenomegaly (HP:0001433) | 2.47444887 |
| 102 | Spontaneous abortion (HP:0005268) | 2.43238759 |
| 103 | Lethargy (HP:0001254) | 2.42047558 |
| 104 | Gangrene (HP:0100758) | 2.40549717 |
| 105 | Granulocytopenia (HP:0001913) | 2.39144402 |
| 106 | Recurrent viral infections (HP:0004429) | 2.39128717 |
| 107 | Gingival bleeding (HP:0000225) | 2.37437579 |
| 108 | Sepsis (HP:0100806) | 2.37416107 |
| 109 | Mitral stenosis (HP:0001718) | 2.36555429 |
| 110 | Cholelithiasis (HP:0001081) | 2.34341257 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 2.33118697 |
| 112 | Cardiovascular calcification (HP:0011915) | 2.33046777 |
| 113 | Abnormality of T cells (HP:0002843) | 2.30817532 |
| 114 | Pustule (HP:0200039) | 2.30793004 |
| 115 | Hypochromic microcytic anemia (HP:0004840) | 2.29696274 |
| 116 | Esophageal varix (HP:0002040) | 2.28308391 |
| 117 | Abnormality of the pleura (HP:0002103) | 2.26705044 |
| 118 | Generalized aminoaciduria (HP:0002909) | 2.26527506 |
| 119 | Spastic diplegia (HP:0001264) | 2.26361740 |
| 120 | Menorrhagia (HP:0000132) | 2.24419619 |
| 121 | Cerebral edema (HP:0002181) | 2.24241824 |
| 122 | Axonal loss (HP:0003447) | 2.23714237 |
| 123 | Abnormality of T cell physiology (HP:0011840) | 2.23546678 |
| 124 | Hypergammaglobulinemia (HP:0010702) | 2.23235399 |
| 125 | T lymphocytopenia (HP:0005403) | 2.21102646 |
| 126 | Abnormality of iron homeostasis (HP:0011031) | 2.20967759 |
| 127 | Pancreatitis (HP:0001733) | 2.19073576 |
| 128 | Malnutrition (HP:0004395) | 2.17962190 |
| 129 | Skin ulcer (HP:0200042) | 2.17227343 |
| 130 | Lymphopenia (HP:0001888) | 2.16349094 |
| 131 | Abnormal platelet volume (HP:0011876) | 2.15877821 |
| 132 | Hemorrhage of the eye (HP:0011885) | 2.15137267 |
| 133 | Neonatal onset (HP:0003623) | 2.15003889 |
| 134 | Abnormality of the peritoneum (HP:0002585) | 2.14880704 |
| 135 | Abnormality of T cell number (HP:0011839) | 2.14447850 |
| 136 | Acute hepatic failure (HP:0006554) | 2.12193898 |
| 137 | Cholecystitis (HP:0001082) | 2.11678296 |
| 138 | Abnormal gallbladder physiology (HP:0012438) | 2.11678296 |
| 139 | Vomiting (HP:0002013) | 2.11665813 |
| 140 | Irritability (HP:0000737) | 2.11489136 |
| 141 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.11289740 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 2.10685281 |
| 143 | Acne (HP:0001061) | 2.10001648 |
| 144 | Hydroxyprolinuria (HP:0003080) | 2.09756623 |
| 145 | Abnormality of proline metabolism (HP:0010907) | 2.09756623 |
| 146 | Late onset (HP:0003584) | 2.09568815 |
| 147 | Toxemia of pregnancy (HP:0100603) | 2.06835391 |
| 148 | Abnormality of the pericardium (HP:0001697) | 2.05124259 |
| 149 | Thrombophlebitis (HP:0004418) | 2.05019584 |
| 150 | Nephritis (HP:0000123) | 2.03412089 |
| 151 | Premature loss of primary teeth (HP:0006323) | 2.03194989 |
| 152 | Skin rash (HP:0000988) | 2.01638268 |
| 153 | Glomerulopathy (HP:0100820) | 2.01014112 |
| 154 | Hypoglycemic seizures (HP:0002173) | 2.00884208 |
| 155 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00721280 |
| 156 | Nausea (HP:0002018) | 2.00124184 |
| 157 | Abnormality of the endocardium (HP:0004306) | 1.99257254 |
| 158 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96466049 |
| 159 | Recurrent pneumonia (HP:0006532) | 1.95811383 |
| 160 | Colitis (HP:0002583) | 1.94910220 |
| 161 | Eczematoid dermatitis (HP:0000976) | 1.94678527 |
| 162 | Chronic otitis media (HP:0000389) | 1.94088816 |
| 163 | Abnormal cartilage morphology (HP:0002763) | 1.93645916 |
| 164 | Metaphyseal cupping (HP:0003021) | 1.92634027 |
| 165 | IgM deficiency (HP:0002850) | 1.92094974 |
| 166 | Increased serum ferritin (HP:0003281) | 1.91878309 |
| 167 | Polycythemia (HP:0001901) | 1.91857534 |
| 168 | Hypermelanotic macule (HP:0001034) | 1.91628755 |
| 169 | Opisthotonus (HP:0002179) | 1.89268367 |
| 170 | Acanthocytosis (HP:0001927) | 1.87909532 |
| 171 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.87865866 |
| 172 | Keratitis (HP:0000491) | 1.87193230 |
| 173 | Abnormality of the gallbladder (HP:0005264) | 1.86662818 |
| 174 | Loss of speech (HP:0002371) | 1.86574142 |
| 175 | Pulmonary embolism (HP:0002204) | 1.86396487 |
| 176 | Increased purine levels (HP:0004368) | 1.84663250 |
| 177 | Hyperuricemia (HP:0002149) | 1.84663250 |
| 178 | Eosinophilia (HP:0001880) | 1.82295690 |
| 179 | Splenomegaly (HP:0001744) | 1.82153498 |
| 180 | Proximal tubulopathy (HP:0000114) | 1.81657657 |
| 181 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81648375 |
| 182 | Increased cerebral lipofuscin (HP:0011813) | 1.80598937 |
| 183 | Hypertriglyceridemia (HP:0002155) | 1.78910750 |
| 184 | Elevated alkaline phosphatase (HP:0003155) | 1.77990364 |
| 185 | Recurrent bacterial skin infections (HP:0005406) | 1.76376885 |
| 186 | Vacuolated lymphocytes (HP:0001922) | 1.76207918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.43046446 |
| 2 | ERN1 | 5.13573431 |
| 3 | RIPK4 | 4.94086982 |
| 4 | FGFR4 | 3.31651271 |
| 5 | SIK1 | 3.27674383 |
| 6 | TRIB3 | 3.19701797 |
| 7 | PKN2 | 2.75312061 |
| 8 | TNK2 | 2.67170041 |
| 9 | FES | 2.41224613 |
| 10 | TAOK3 | 2.40176780 |
| 11 | EPHB1 | 2.24660387 |
| 12 | TAOK1 | 2.24356162 |
| 13 | MST1R | 2.07626212 |
| 14 | TYK2 | 2.04843887 |
| 15 | PRPF4B | 1.88566888 |
| 16 | TBK1 | 1.85605341 |
| 17 | MAP2K3 | 1.76244037 |
| 18 | PIK3CG | 1.63812298 |
| 19 | TESK2 | 1.62939777 |
| 20 | ERBB4 | 1.62165221 |
| 21 | TTN | 1.60242413 |
| 22 | PTK6 | 1.59740515 |
| 23 | GRK6 | 1.52072707 |
| 24 | FLT3 | 1.47494991 |
| 25 | SYK | 1.47175997 |
| 26 | INSRR | 1.45954643 |
| 27 | CSK | 1.44010741 |
| 28 | ABL2 | 1.43369629 |
| 29 | SIK3 | 1.43230911 |
| 30 | BLK | 1.39811209 |
| 31 | MAPK11 | 1.37594799 |
| 32 | NEK9 | 1.37298856 |
| 33 | MAP3K14 | 1.37177105 |
| 34 | LYN | 1.33967963 |
| 35 | IRAK3 | 1.32586260 |
| 36 | SMG1 | 1.30416712 |
| 37 | KDR | 1.29088499 |
| 38 | TAOK2 | 1.28749044 |
| 39 | JAK2 | 1.27763494 |
| 40 | YES1 | 1.27252652 |
| 41 | RIPK1 | 1.25572974 |
| 42 | MAP4K1 | 1.24204943 |
| 43 | TXK | 1.23388728 |
| 44 | MAP3K3 | 1.22781068 |
| 45 | TGFBR2 | 1.17864026 |
| 46 | MAP2K4 | 1.17674636 |
| 47 | JAK1 | 1.13342042 |
| 48 | PRKD2 | 1.11798853 |
| 49 | MAP3K11 | 1.06823739 |
| 50 | CDK19 | 1.03397989 |
| 51 | LCK | 1.03350975 |
| 52 | PRKAA2 | 1.00682547 |
| 53 | CAMK1D | 0.99606904 |
| 54 | IRAK4 | 0.94055497 |
| 55 | IKBKE | 0.93764753 |
| 56 | MARK3 | 0.93479901 |
| 57 | MAP3K7 | 0.92514741 |
| 58 | MAP3K6 | 0.90892806 |
| 59 | MAPK4 | 0.87816122 |
| 60 | MARK2 | 0.86648563 |
| 61 | CSF1R | 0.83891350 |
| 62 | IRAK1 | 0.83628195 |
| 63 | BMX | 0.82940916 |
| 64 | LRRK2 | 0.82770157 |
| 65 | ZAP70 | 0.81261280 |
| 66 | MYLK | 0.79205819 |
| 67 | IRAK2 | 0.78238342 |
| 68 | FRK | 0.76674615 |
| 69 | DAPK2 | 0.75942860 |
| 70 | KIT | 0.75938106 |
| 71 | EPHA3 | 0.75120242 |
| 72 | BTK | 0.74729811 |
| 73 | MET | 0.74162868 |
| 74 | MAP3K10 | 0.73465265 |
| 75 | PINK1 | 0.72841475 |
| 76 | CDK6 | 0.71627941 |
| 77 | PIK3CA | 0.71437796 |
| 78 | LATS1 | 0.68879012 |
| 79 | MAPK12 | 0.68402332 |
| 80 | MAP3K13 | 0.67134292 |
| 81 | PTK2 | 0.67043985 |
| 82 | MAP3K2 | 0.65465001 |
| 83 | GSK3A | 0.62150142 |
| 84 | FGFR3 | 0.61385430 |
| 85 | FYN | 0.61357970 |
| 86 | PDPK1 | 0.60479206 |
| 87 | MAP2K2 | 0.58923914 |
| 88 | STK10 | 0.57798144 |
| 89 | PTK2B | 0.57279681 |
| 90 | PRKACG | 0.57044173 |
| 91 | RAF1 | 0.53878691 |
| 92 | IKBKB | 0.53424372 |
| 93 | OBSCN | 0.53128212 |
| 94 | FGR | 0.52328118 |
| 95 | PRKCZ | 0.52158500 |
| 96 | MAP3K1 | 0.51482216 |
| 97 | HCK | 0.50784813 |
| 98 | PRKAA1 | 0.50469353 |
| 99 | MAP3K5 | 0.49515598 |
| 100 | KSR2 | 0.49334106 |
| 101 | SIK2 | 0.48310973 |
| 102 | STK38 | 0.48050335 |
| 103 | MAP3K8 | 0.47870117 |
| 104 | MAPKAPK2 | 0.46978128 |
| 105 | JAK3 | 0.45867472 |
| 106 | MAP2K6 | 0.45812200 |
| 107 | STK11 | 0.45424114 |
| 108 | EGFR | 0.44935720 |
| 109 | TIE1 | 0.44772183 |
| 110 | PAK4 | 0.44613504 |
| 111 | DYRK1B | 0.44036371 |
| 112 | ERBB2 | 0.43248970 |
| 113 | ITK | 0.42769814 |
| 114 | TRPM7 | 0.42166093 |
| 115 | PRKG2 | 0.41838385 |
| 116 | MAP2K1 | 0.41408484 |
| 117 | RPS6KC1 | 0.40771179 |
| 118 | RPS6KL1 | 0.40771179 |
| 119 | DYRK3 | 0.40503288 |
| 120 | PDK1 | 0.38393924 |
| 121 | ABL1 | 0.38223317 |
| 122 | CAMK1G | 0.38099283 |
| 123 | CDC42BPA | 0.37958432 |
| 124 | FGFR2 | 0.37867631 |
| 125 | PRKCQ | 0.37850746 |
| 126 | CAMK2G | 0.37592777 |
| 127 | RET | 0.37012844 |
| 128 | ALK | 0.36985254 |
| 129 | PDK3 | 0.36499907 |
| 130 | PDK4 | 0.36499907 |
| 131 | NME2 | 0.36381662 |
| 132 | PIM1 | 0.35601993 |
| 133 | STK38L | 0.35065839 |
| 134 | HIPK2 | 0.34667305 |
| 135 | SGK3 | 0.33681841 |
| 136 | MATK | 0.33306316 |
| 137 | PRKCD | 0.33098209 |
| 138 | TEC | 0.32875921 |
| 139 | RPS6KA6 | 0.30099120 |
| 140 | BMPR2 | 0.29826155 |
| 141 | MAPK7 | 0.28772233 |
| 142 | PRKD1 | 0.27661882 |
| 143 | MAP3K12 | 0.25041766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.24516422 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38828524 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26091826 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.23044828 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96774266 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.73267744 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61344996 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59414002 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56776995 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.53997071 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48044207 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47944111 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.44235900 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.35512139 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34566024 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.33256316 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32715089 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.24733616 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.24016213 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.21683119 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.16331088 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 2.11914811 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04687943 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03017614 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.99073586 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96435326 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95657523 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91328038 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.87596595 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87201767 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.86775521 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82064194 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80094509 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78180494 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.75983223 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74680525 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73742119 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.69346846 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68833025 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.68369251 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.65961426 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64516320 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62264538 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60733647 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58087445 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57305453 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53939040 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53797449 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 1.52846431 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48269358 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47339596 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46750012 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46503587 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42813772 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42473881 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.40647914 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39569436 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.39257118 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 1.36431584 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.34943864 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33653328 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31883622 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28777909 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28616817 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25776295 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24979616 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23877873 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21279231 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 1.19559387 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19487509 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19014178 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18754058 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18188783 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16867417 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 1.14006194 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12899945 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09842175 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06787652 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 1.03411769 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 1.03070403 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 1.02131888 |
| 82 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02058332 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99244617 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96462982 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95407121 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94160549 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93396444 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.93382423 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91634852 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.87691235 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86704277 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81299476 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80067008 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79994471 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78456570 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78406960 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.77993578 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77447009 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77367675 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77018162 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77005991 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76443318 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76161178 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75647960 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75157523 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74462295 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.74409588 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73623830 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72008713 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71166407 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70574022 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69503846 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69403544 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68249514 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65416391 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60746940 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59177050 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56744116 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56539522 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55873424 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53803793 |
| 122 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50850031 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50838185 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48106979 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48023120 |
| 126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47258032 |
| 127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46758708 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45334341 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41973148 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41605128 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41058326 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40878661 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.40582395 |
| 134 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38619037 |
| 135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38165815 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36562193 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36073432 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.35700502 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32896417 |
| 140 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29595633 |
| 141 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23603726 |
| 142 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21978247 |
| 143 | Thyroid cancer_Homo sapiens_hsa05216 | 0.20902354 |
| 144 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20040632 |
| 145 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19818409 |
| 146 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17414025 |
| 147 | Lysosome_Homo sapiens_hsa04142 | 0.16024836 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12868759 |
| 149 | Leishmaniasis_Homo sapiens_hsa05140 | 0.12726638 |
| 150 | Pertussis_Homo sapiens_hsa05133 | 0.11083147 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09703397 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07807342 |
| 153 | Legionellosis_Homo sapiens_hsa05134 | 0.06364227 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04349280 |
| 155 | Other glycan degradation_Homo sapiens_hsa00511 | 0.03782536 |
| 156 | Malaria_Homo sapiens_hsa05144 | 0.02236568 |
| 157 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.00547777 |
| 158 | Amoebiasis_Homo sapiens_hsa05146 | 0.00247887 |
| 159 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00049989 |
| 160 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0960793 |
| 161 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0938961 |
| 162 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0886993 |
| 163 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0647664 |
| 164 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0586658 |
| 165 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0555415 |
| 166 | Tuberculosis_Homo sapiens_hsa05152 | -0.0528085 |
| 167 | Hepatitis C_Homo sapiens_hsa05160 | -0.0355589 |
| 168 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0337005 |
| 169 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0264495 |
| 170 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0144302 |

